BioCentury | Aug 27, 2020
Distillery Therapeutics

IL-25 to mitigate GvHD in the GI tract after transplant

...1, 2020doi:10.1126/scitranslmed.aaw0720CONTACT: Daigo Hashimoto, Hokkaido University, Sapporo, Japanemail: d5hash@pop.med.hokudai.ac.jpCONTACT: Takanori Teshima, same affiliation as aboveemail: teshima@med.hokudai.ac.jp Claire Quang Hokkaido University Interleukin-25...
BioCentury | Dec 8, 2017
Targets & Mechanisms

Epiphenomena at ASH

...knockout decreased the number of leukemic stem cells compared with normal STAP1 or STAP2 expression. Hokkaido University...
BioCentury | Oct 31, 2017
Distillery Therapeutics

Transplant

...published online Oct. 24, 2017 doi:10.1084/jem.20170418 CONTACT: Takanori Teshima, Hokkaido University, Sapporo, Japan email: teshima@med.hokudai.ac.jp Michael Leviten Hokkaido University Defensin...
BioCentury | Oct 27, 2017
Preclinical News

RSPO1 restores gut biome in GvHD

...Researchers at Hokkaido University (Sapporo, Japan) and colleagues found that R-Spondin 1 ( RSPO1 ) stimulates differentiation...
...increases secretion of antimicrobial peptides from other cell types in addition to Paneth cells. Jaime De Leon Hokkaido University R-Spondin...
BioCentury | Mar 21, 2017
Distillery Therapeutics

Dermatology

...published online March 1, 2017 doi:10.1038/ncomms14610 CONTACT: Akio Kihara, Hokkaido University, Sapporo, Japan email: kihara@pharm.hokudai.ac.jp Winnie Pong Hokkaido University Patatin...
BioCentury | Jan 18, 2017
Distillery Therapeutics

Autoimmune disease

...Fujikura, Hokkaido University, Sapporo, Japan email: d-fuji@czc.hokudai.ac.jp CONTACT: Toshimitsu Uede, same affiliation as above email: uedetoshimitsu@gmail.com Winnie Pong Hokkaido University Tumor...
BioCentury | Jun 22, 2015
Company News

R-Tech Ueno Ltd, Hokkaido University deal

...to license the compound following a proof-of-concept study. R-Tech Ueno Ltd . (JASDAQ:4573), Tokyo, Japan Hokkaido University...
BioCentury | Apr 2, 2015
Distillery Therapeutics

Therapeutics: Toll-like receptor 3 (TLR3)

...Matsumoto, M. et al. Nat. Commun.; published online Feb. 18, 2015 doi:10.1038/ncomms7280 CONTACT: Tsukasa Seya, Hokkaido University...
BioCentury | Feb 19, 2015
Distillery Techniques

Techniques: Octaarginine-modified liposomes for intracellular mAb delivery

...Y. et al. J. Pharm. Sci.; published online Dec. 26, 2014 doi:10.1002/jps.24310 CONTACT: Hideyoshi Harashima, Hokkaido University...
BioCentury | Aug 21, 2014
Distillery Therapeutics

Indication: Dermatology

...N. et al. Sci. Transl. Med.; published online July 16, 2014; doi:10.1126/scitranslmed.3008227 Contact: Riichiro Abe, Hokkaido University...
Items per page:
1 - 10 of 28
BioCentury | Aug 27, 2020
Distillery Therapeutics

IL-25 to mitigate GvHD in the GI tract after transplant

...1, 2020doi:10.1126/scitranslmed.aaw0720CONTACT: Daigo Hashimoto, Hokkaido University, Sapporo, Japanemail: d5hash@pop.med.hokudai.ac.jpCONTACT: Takanori Teshima, same affiliation as aboveemail: teshima@med.hokudai.ac.jp Claire Quang Hokkaido University Interleukin-25...
BioCentury | Dec 8, 2017
Targets & Mechanisms

Epiphenomena at ASH

...knockout decreased the number of leukemic stem cells compared with normal STAP1 or STAP2 expression. Hokkaido University...
BioCentury | Oct 31, 2017
Distillery Therapeutics

Transplant

...published online Oct. 24, 2017 doi:10.1084/jem.20170418 CONTACT: Takanori Teshima, Hokkaido University, Sapporo, Japan email: teshima@med.hokudai.ac.jp Michael Leviten Hokkaido University Defensin...
BioCentury | Oct 27, 2017
Preclinical News

RSPO1 restores gut biome in GvHD

...Researchers at Hokkaido University (Sapporo, Japan) and colleagues found that R-Spondin 1 ( RSPO1 ) stimulates differentiation...
...increases secretion of antimicrobial peptides from other cell types in addition to Paneth cells. Jaime De Leon Hokkaido University R-Spondin...
BioCentury | Mar 21, 2017
Distillery Therapeutics

Dermatology

...published online March 1, 2017 doi:10.1038/ncomms14610 CONTACT: Akio Kihara, Hokkaido University, Sapporo, Japan email: kihara@pharm.hokudai.ac.jp Winnie Pong Hokkaido University Patatin...
BioCentury | Jan 18, 2017
Distillery Therapeutics

Autoimmune disease

...Fujikura, Hokkaido University, Sapporo, Japan email: d-fuji@czc.hokudai.ac.jp CONTACT: Toshimitsu Uede, same affiliation as above email: uedetoshimitsu@gmail.com Winnie Pong Hokkaido University Tumor...
BioCentury | Jun 22, 2015
Company News

R-Tech Ueno Ltd, Hokkaido University deal

...to license the compound following a proof-of-concept study. R-Tech Ueno Ltd . (JASDAQ:4573), Tokyo, Japan Hokkaido University...
BioCentury | Apr 2, 2015
Distillery Therapeutics

Therapeutics: Toll-like receptor 3 (TLR3)

...Matsumoto, M. et al. Nat. Commun.; published online Feb. 18, 2015 doi:10.1038/ncomms7280 CONTACT: Tsukasa Seya, Hokkaido University...
BioCentury | Feb 19, 2015
Distillery Techniques

Techniques: Octaarginine-modified liposomes for intracellular mAb delivery

...Y. et al. J. Pharm. Sci.; published online Dec. 26, 2014 doi:10.1002/jps.24310 CONTACT: Hideyoshi Harashima, Hokkaido University...
BioCentury | Aug 21, 2014
Distillery Therapeutics

Indication: Dermatology

...N. et al. Sci. Transl. Med.; published online July 16, 2014; doi:10.1126/scitranslmed.3008227 Contact: Riichiro Abe, Hokkaido University...
Items per page:
1 - 10 of 28